What is MDAI's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for MDAI.

Stock Ratings / Health Care / MDAI / options

SRTS (41) DXR (47) SNWV (51) DAVI (47) ⌘ Pro Terminal →

Spectral AI Inc. (Class A) (MDAI) Options Positioning, Max Pain & Unusual Sweeps

$1.52 -0.65% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.52

Spectral AI Inc. (Class A) (MDAI) carries a Roarable Rating of E (Strong Sell) with 16/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E • RED ALERT Cap $49.2M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on MDAI Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is MDAI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-03, Spectral AI Inc. (Class A) (NASDAQ: MDAI) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 16/100 at a spot price of $1.52 (-0.65% 1D, market cap $49.2M). Pillar breakdown: Fundamental Cash Engine 3/20, Institutional 13F & Options Flow 6/20, SEC Balance-Sheet Forensics 4/20, FRED Macro Regime Fit 3/20, and Executive Insider Alignment 3/20. Across 1015 tracked Health Care issuers, MDAI ranks #1011 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does MDAI compare to SRTS and DXR in the Health Care sector?

▼

Within the Health Care sector (Medical/Dental Instruments), MDAI carries a Roarable E (16/100 RQD), trailing P/E of N/A, gross margin of 45.4%, and ROIC of -35.0%. By comparison, SRTS (Sensus Healthcare Inc.) holds a D- grade (41/100 RQD, P/E N/A, ROIC -31.3%, cap $45.4M) and DXR (Daxor Corporation) posts a D grade (47/100 RQD, P/E N/A, ROIC —, cap $53.7M). Among the 5-stock peer group, SNWV leads on earnings multiple (3.8x) while SNWV leads on capital efficiency (67.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for MDAI?

▼

Per MDAI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001833498), Spectral AI Inc. (Class A) generated $19.6M in revenue (-33.6% YoY), -$7.6M in net income, and -$9.9M in free cash flow against $21.4M in total assets and $5.5M in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.52 (-0.31%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 3/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (16/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-12.7% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 Quant Analysts Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR RQD RADARRw E · Rk E

Each axis scored 0–20

12M PRICE TARGET CONE-19.1% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MDAI)Realized 20D OHLCV Swing Band: ±8%

Deterministic 5-Pillar Attribution (16/100 Composite)

🔍 WHY MDAI SCORES 16/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+6/20 pts (38% of score)

20D Institutional Volume Accumulation (±8% realized swing band)

▲ #2 Bullish Driver: Cash Engine Quality+4/20 pts (25% of score)

SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 45.4% Gross Margin

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$1.56-3.2% Next Q

Q2 (-2Q)

Grade E$1.51+1.3% Next Q

Q3 (-1Q)

Grade E$1.53-0.7% Next Q

Current

Grade E$1.52-12.7% Hist 90D α

Trajectory: E (24) → E (16)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a MDAI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While MDAI currently carries a cautious 16/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.58) and Max Pain ($1.60) forces dealer call-delta covering toward $3.12.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $MDAI• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “MDAI Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 18%NO 82%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±8%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (MDAI)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for MDAI.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MDAI)

✓Walkthrough of MDAI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MDAI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -33.04%🛡️ HOLDING TREND SUPPORT

2026-11-03O $1.57H $1.57L $1.52C $1.52VOL 120.8K

RES: $1.81SUP: $1.41SMA50: $1.58SMA200: $1.70

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MDAI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MDAI Butterfly Map → + Track MDAI →

Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle

8.0%/yr Implied 5Y Growth

vs. -33.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on MDAI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MDAI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MDAI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MDAI)

Health Care Rank #1011 of 1015 ⚔️ SRTS vs MDAI Full Matrix →

1. Head-to-Head Health Care Peer Comparison (MDAI vs. SRTS, DXR, SNWV, DAVI)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Spectral AI Inc. (Class A) (MDAI) ranks #1011 by composite RQD confidence (16/100, grade E) and #748 by equity capitalization ($49.2M). Within this direct 5-issuer industry benchmark cohort, SNWV leads on earnings valuation at 3.8x trailing P/E, while SNWV leads on capital efficiency and profitability with 67.3% ROIC and 77.1% gross margin. SNWV currently holds the highest overall quantitative score in the immediate peer group at 51/100 (D) compared with MDAI at 16/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MDAI ACTIVE Spectral AI Inc. (Class A)	E	16/100	—	45.4%	-35.0%	-0.65%	$49.2M	Benchmark Subject
SRTS Sensus Healthcare Inc.	D-	41/100	—	43.2%	-31.3%	-0.36%	$45.4M	/srts-vs-mdai →
DXR Daxor Corporation	D	47/100	—	—	—	-2.17%	$53.7M	/dxr-vs-mdai →
SNWV SANUWAVE Health Inc.	D	51/100	3.8x	77.1%	67.3%	+13.59%	$44.3M	/snwv-vs-mdai →
DAVI Davion Healthcare Plc	D	47/100	—	—	—	-11.31%	$42.0M	/davi-vs-mdai →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001833498 ↗

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Spectral AI Inc. (Class A) (MDAI) reported GAAP revenue of $19.6M (-33.6% vs. FY2024 revenue of $29.6M , and +8.8% cumulative change since FY2023) , GAAP net income of -$7.6M, operating cash flow of -$9.9M, and free cash flow of -$9.9M (-7.8% YoY). On the balance sheet, MDAI closed FY2025 with $21.4M in total assets against $5.5M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 2/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$19.6M	-$7.6M	-$9.9M	-$9.9M	$21.4M	$5.5M
FY2024 (FY)	2024-12-31	$29.6M	-$15.2M	-$9.2M	-$9.2M	$12.1M	—
FY2023 (FY)	2023-12-31	$18.1M	-$20.9M	-$13.2M	-$13.2M	—	—

3. MDAI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MDAI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does MDAI compare to SRTS and DXR in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for MDAI?

Where is MDAI trading relative to its 50-day, 200-day, and 52-week technical levels?

MDAI last traded at $1.52 (-0.65% on volume of 131,796 shares), positioning the stock -3.80% below its 50-day simple moving average ($1.58) and -10.59% below its 200-day simple moving average ($1.70). Across its 52-week range of $1.18 to $2.97, MDAI sits at the 19.0% percentile with a 14-day RSI of 46.1 (NEUTRAL RANGE) and an implied next-earnings move of ±8.0% ($1.40 to $1.64).

Direct Sub-Reports: MDAI RQD Cockpit MDAI 12M Forecast MDAI Earnings & Move MDAI Dividends & DRIP MDAI Insiders & 13F MDAI Whale Options MDAI Profit Sankey MDAI News & Why

ROARABLE RATING BRIEF • RQD 16/100 (E) ✓ SEC XBRL & RQD VERIFIED

MDAI — Spectral AI Inc. (Class A): What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit

Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Spectral AI Inc. (Class A) (MDAI) earns a live Roarable RQD composite score of 16/100, corresponding to a E letter grade (Roarable Strong Sell) at a spot price of $1.52 (-0.65% 1D, market capitalization $49.2M).

Fundamental Cash Engine (3/20): Anchored by return on invested capital (ROIC) of -35.0%, gross margin of 45.4%, operating margin of -43.8%, and free cash flow yield of -19.63%.
Whale 13F & Options Flow (6/20) + Insider Conviction (3/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
Macro Regime Fit (3/20) + Forensic Balance Sheet (4/20): Incorporates a 1.00x equity beta, Altman Z-Score of 0.20, Piotroski F-Score of 2/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Spectral AI Inc. (Class A) is listed on NASDAQ under the ticker MDAI and is classified in the Health Care sector and the Medical/Dental Instruments industry. The profile does not describe its products, customers, or revenue model. Revenue for FY 2025 is reported at $19. Gross margin is reported at 45.4% per market data.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Spectral AI Inc. (Class A) (MDAI) reported $19.6M in annual revenue (up from $29.6M in FY2024, -33.6% YoY) and -$7.6M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($18.1M revenue, -$20.9M net income) through FY2025, MDAI scaled operating cash flow to -$9.9M and free cash flow to -$9.9M, backed by $21.4M in total assets against $5.5M in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

🐂 Primary Bull Case (E • RQD 16/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of -19.63% and institutional whale pillar of 6/20. With Fundamental Cash Engine at 3/20 and Institutional Whale Flow at 6/20, sustained execution supports upside toward the upper end of the $1.18 – $2.97 52-week range.
🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against -43.8% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream suppliers, downstream customers, and sector correlations beyond the Health Care sector and Medical/Dental Instruments industry classification are — A prospective investor would need external supply-chain disclosure to assess second-order bottlenecks.

Key Question #1: Can MDAI sustain or expand its -43.8% operating margin and -35.0% ROIC against Medical/Dental Instruments peers over the next 4 quarters?
Key Question #2: Following FY2025 revenue of $19.6M and free cash flow of -$9.9M, how will capital allocation balance growth reinvestment against $5.5M in total debt?
Key Question #3: How sensitive is MDAI's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

MDAI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Spectral AI Inc. (Class A) (MDAI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to MDAI Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo! Finance Canada • 1d ago

Spectral AI, Inc. (MDAIW) Stock Price, News, Quote & History

Yahoo! Finance Canada report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance UK • 1d ago

Spectral AI, Inc. (MDAI) Seasonal returns chart

Yahoo Finance UK report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE https://www.dars.gov.et/ • 1d ago

Spectral AI (MDAI) Slips 2.55% to $1.53 as Shares Test Lower End of Recent Range - Negative Gamma

https://www.dars.gov.et/ report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingKey • 1d ago

Most Active Stocks Today: U.S. Market

TradingKey report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo! Finance Canada • 1d ago

QScreen AI Inc. (QAI.CN) Seasonal Returns Chart - Yahoo Finance

Yahoo! Finance Canada report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟢 CATALYST TradingKey • 1d ago

Top U.S. Stock Gainers: Biggest Price Increases

TradingKey report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingKey • 2d ago

Top U.S. Stock Losers: Biggest Price Declines

TradingKey report covering Spectral AI Inc. (Class A) (MDAI) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo • 6d ago

Spectral AI Schedules 2026 Third Quarter Financial Results and Conference Call

DALLAS, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment d

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

MDAI Bull vs. Bear Conversation Board — What's Your Call at $1.52?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON MDAI 🐻 33% BEARISH CONVICTION

SI SiliconVal_Bull RQD DEBATE OPENER • Growth & Tech Investor 🐂 BULLISH 🎯 Target: $1.88 (+22.9%)

📌 Pinned Debate

Cash of $15.4M exceeds reported debt of $5.5M in FY 2025 while market data shows gross margin of 45.4%.

The street is overcomplicating Spectral AI Inc. (Class A) (MDAI). Cash of $15.4M exceeds reported debt of $5.5M in FY 2025 while market data shows gross margin of 45.4%.. With an RQD score of 16/100 (E) and Forensic Balance Sheet at 4/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $1.65.

RetailWhale_TX 🐂 BULL

Both sides have a point here — MDAI's 4/20 balance sheet score keeps downside contained, so the real swing factor next earnings call is backlog and FCF conversion.

RE RedlineAuditor RQD DEBATE OPENER • Accounting Quality Watch 🐻 BEARISH 🎯 Target: $1.32 (-13.7%)

Spot @ $1.53

Operating margin of -43.8%, ROIC of -35%, and Altman Z-Score of 0.2 signal severe cash burn and financial distress.

I respect the product at Spectral AI Inc. (Class A), but the stock at $1.53 is a different story. Operating margin of -43.8%, ROIC of -35%, and Altman Z-Score of 0.2 signal severe cash burn and financial distress.. FCF yield is -19.63% and RQD sits at 16/100 (E) — why pay up here when you can wait for next quarter's numbers?